| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 07/27/2005 | CN1646137A Method for treating and preventing hyperparathyroidism |
| 07/27/2005 | CN1646124A Use of materials having zinc ionophoric behavior |
| 07/27/2005 | CN1646120A Antineoplastic combinations |
| 07/27/2005 | CN1646114A Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
| 07/27/2005 | CN1646090A New composition including a pigment assembly comprising a mica core |
| 07/27/2005 | CN1644561A Method for producing polymeric sol of calcium phosphate compound and method for coating the same on a metal implant |
| 07/27/2005 | CN1212154C Gel delivery vehicles for anticellular proliferative agent |
| 07/27/2005 | CN1212130C Medicine for treating psoriasis, ichthyosis and eczema |
| 07/27/2005 | CN1212127C Medicated sanitary article for treating gynopathy and its preparation |
| 07/27/2005 | CN1212126C Nano hydroxy apatite calcium supplementing agent |
| 07/27/2005 | CN1212125C Strontium-calcium composite tonic series and its preparation |
| 07/26/2005 | US6921768 Cytostatic cerium compounds |
| 07/26/2005 | US6921540 Hypotonic brines comprising mixtures of sodium, potassium, magnesium, calcium, chlorine and sulfates in water, used for prevention of inflammation of mucous membranes and for dissolving plugs in ears |
| 07/21/2005 | WO2005066371A2 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 07/21/2005 | WO2005065731A1 Antimicrobial contact lenses and methods for their production |
| 07/21/2005 | WO2005065723A1 RAPID SCREENING METHODS FOR FUNCTIONAL p53 USING THE RESPONSE PATTERN TO ARSENIC TRIOXIDE |
| 07/21/2005 | WO2005065695A1 Method and formula for suppression of cancer, metastasis, vascularization, and pain suppression |
| 07/21/2005 | WO2005065669A1 Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
| 07/21/2005 | WO2005065661A2 Immediate, controlled and sustained release formulations of galanthamine |
| 07/21/2005 | WO2005065079A2 Medical implants and fibrosis-inducing agents |
| 07/21/2005 | WO2005056027A3 Solvent for biogenic active pharmaceutical ingredients |
| 07/21/2005 | WO2005051487A3 A ruminant zinc containing bolus |
| 07/21/2005 | WO2005049012A3 Tryptophan for use in promoting and maintaining abstinence |
| 07/21/2005 | US20050159461 Treating cancer with a synergistic mixtures; anticarcinogenic agents; epothilone has secondary amide instead of an ester |
| 07/21/2005 | US20050159426 Novartis drug called Imatinib, 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide, methanosulfonate; synergistic mixture with a second antineoplastic agent |
| 07/21/2005 | US20050158703 Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy |
| 07/21/2005 | US20050158407 Antipyrotic and method of manufacturing the same |
| 07/21/2005 | US20050158404 Composition and method for treatment of acne |
| 07/21/2005 | US20050158401 Associated with decreased nitric oxide bioavailability; using an arginine- and/or arginase-inhibitor based therapy; asthma, sickle cell disease, and pulmonary hypertension |
| 07/21/2005 | US20050158400 Antimicrobial ceramic glaze |
| 07/21/2005 | US20050158399 Transparent and homogenized polymeric sol; good wettability and bioactivity |
| 07/21/2005 | US20050158393 Polymeric material associated with colloidal metal particles, especially gold, suitable for injection or implantation |
| 07/21/2005 | US20050158374 Compositions and dosage forms for enhanced absorption of metformin |
| 07/21/2005 | US20050158290 Process for the preparation of a nutrient formulation |
| 07/21/2005 | US20050158274 Therapeutic use of a fibrosing agent to induces a fibrotic response at a specific site, thereby providing the patient with pulmonary sealing |
| 07/21/2005 | US20050158264 Sympathetic nerve-stimulating fragrant compositions |
| 07/21/2005 | US20050158263 Pyrithione biocides enhanced by zinc metal ions and organic amines |
| 07/21/2005 | US20050158252 Method and compositions for oral hygiene |
| 07/21/2005 | US20050158251 Oral composition of solvent, an oxidant and alkyl cellulose in varnish form |
| 07/21/2005 | CA2551946A1 Immediate, controlled and sustained release formulations of galantamine |
| 07/21/2005 | CA2551816A1 Antimicrobial contact lenses and methods for their production |
| 07/20/2005 | EP1555008A1 Tooth bleaching composition |
| 07/20/2005 | EP1554315A1 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
| 07/20/2005 | EP1553936A2 Treatment and rehydration composition which is used to limit the side effects of gastro-enteritis in adults |
| 07/20/2005 | EP1409028A4 Bandage using molecular sieves |
| 07/20/2005 | EP1112178A4 Method for treating calcium borate ores to obtain useful boron compounds |
| 07/20/2005 | CN1643630A Photovoltaic cell interconnection |
| 07/20/2005 | CN1643382A A cytocapacity test |
| 07/20/2005 | CN1642978A Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 07/20/2005 | CN1642514A Composite powder and cosmetic containing the same |
| 07/20/2005 | CN1640412A 西地碘口含片 West to iodine buccal tablets |
| 07/20/2005 | CN1640411A Matched reagent for removing tooth decay |
| 07/20/2005 | CN1211124C Thixotropic formulations for filling hard capsules |
| 07/20/2005 | CN1211118C Formula of medicine for treating bone fracture |
| 07/20/2005 | CN1211117C Preparation of Xinxue granules |
| 07/20/2005 | CN1211115C Chinese materia medica preparation for treating burn and scald and method for preparing the same |
| 07/20/2005 | CN1211112C Gubenhuiyuan traditional Chinese medicine composition and its method for producing oral liquid |
| 07/20/2005 | CN1211092C External use medicine for treating bromhidrosis |
| 07/20/2005 | CN1211074C Solid-state liposome contaniing calcareous and its preparation method |
| 07/20/2005 | CN1211063C Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/19/2005 | US6919364 Microbiological control in animal processing |
| 07/19/2005 | US6919340 Kinase moderators; controlling gene expression; immunosuppressants; autoimmune disease; rheumatic disorders; skin disorders; antitumor agents; anticancer agents |
| 07/19/2005 | US6919330 Formulations of drugs |
| 07/19/2005 | US6919070 Stomatic composition |
| 07/14/2005 | WO2005063235A1 Anticancer therapy-aiding composition comprising polyphenol, and ascorbic acid or the derivatives |
| 07/14/2005 | WO2005063184A1 Methods and compositions for oral hygiene |
| 07/14/2005 | WO2005062810A2 Treatment of primary and metastatic neoplastic diseases with tetraarsenic decaoxide |
| 07/14/2005 | WO2005046360A3 Carbohydate and electrolyte replacement composition |
| 07/14/2005 | WO2005039320A3 Composition for the activation of the immune system |
| 07/14/2005 | US20050154213 Novel boronate esters |
| 07/14/2005 | US20050153940 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 07/14/2005 | US20050153930 Via gadolinium compounds as calcium channel blockers; drug screening |
| 07/14/2005 | US20050153020 in the form of powders, infusion solutions or sports drinks, used for correcting mammalian phosphate depletion |
| 07/14/2005 | US20050152995 comprising contacting tissues with agents that prevents glial scar formation and optionally agent that increases bcl-2 protein levels in neurons |
| 07/14/2005 | US20050152994 Composition and process for coloring and preserving wood |
| 07/14/2005 | US20050152993 herbal extracts from mallow, rosemary and eucalyptus, used as body washes, sprays and creams for treatment of skin disorders |
| 07/14/2005 | US20050152992 comprising a dispersion of wax and silver particles in amounts ranging from about 0.005% to about 0.3% by weight; particle sizes from about 5 nanometers to about 100 nanometers |
| 07/14/2005 | US20050152990 Fluid swellable fibrous matrix containing minerals; artificial bone |
| 07/14/2005 | US20050152989 Method for treating irritable bowel syndrome |
| 07/14/2005 | US20050152988 xenon and nitrous oxide (N2O) can behave as N-methyl-D-aspartate (NMDA) glutamate receptor antagonists; neurodegenerative diseases; drug overdose; neuroprotective potential, on sensitization to D-amphetamine, of argon could involve an agonist action with respect to GABAA receptors |
| 07/14/2005 | US20050152952 Phaseolamin compositions and methods for using the same |
| 07/14/2005 | US20050152891 for delivery and controlled release to treatment sites, such as in the area of an implanted stents |
| 07/14/2005 | US20050152890 spheres of activated carbon, optionally mixed with carriers or diluents, used for treating or prevention of urogenital or liver dsioders; detoxification |
| 07/14/2005 | US20050150941 Method and system for tracking sodium intake |
| 07/13/2005 | EP1552841A1 Arsenic sulfide compounds and derivates thereof for the treatment of malignancies |
| 07/13/2005 | EP1552840A1 Use of a xenon/carbon monoxide mixture for the protection of cells |
| 07/13/2005 | EP1552745A1 Therapeutic combinations of venous dilators and arterial dilators |
| 07/13/2005 | EP1551763A1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 07/13/2005 | EP1551429A2 Antiseptic solutions containing silver chelated with polypectate and edta |
| 07/13/2005 | EP1551427A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 07/13/2005 | EP1551358A2 Topical treatment for skin irritation |
| 07/13/2005 | EP1463688B1 Use of an antimicrobial glass ceramic for dental care and oral hygiene |
| 07/13/2005 | EP1030567B1 System for dialysis and shock treatment |
| 07/13/2005 | CN1639318A Antimicrobial composition |
| 07/13/2005 | CN1639191A 鼠李糖结合蛋白 Rhamnose-binding protein |
| 07/13/2005 | CN1638797A Cancer treatment |
| 07/13/2005 | CN1638781A Carbon monoxide as a biomarker and therapeutic agent |
| 07/13/2005 | CN1638779A Utilization of phosphatidylserine in the treatment of attention deficit syndrome (ADHS) |
| 07/13/2005 | CN1638764A Eye drops containing tetrazole derivative |
| 07/13/2005 | CN1638755A Body temperature elevating agents |